The Working Group

Since May 2015, the AG Pro Biosimilars, which is under the umbrella of Pro Generika e.V., has been open to all biosimilar companies in Germany. The AG Pro Biosimilars is committed

to fair and sustainable competitive conditions for biosimilars. Because once these are in supply, all patients have access to the biopharmaceutical drug therapies they need.

Our Positions

fair competition

constructive dialogue

more transparency

About us
Our companies

The AG Pro Biosimilars is an association of nine companies that market biosimilars in Germany.

To the companies
Chair and office

The chair and office of the AG Pro Biosimilars present themselves here.

Share On Facebook
Share On Twitter
Share On Linkedin
Contact us